| Phase 4 |
| NCT06843044 |
Efficacy and Safety of Ranquilon in Patients With Anxiety Disorders Due to Neurasthenia… |
Anxiety |
Recruiting |
2025-07-08 |
| NCT06321341 |
Efficacy and Safety of Vespireit, Prolonged-release Tablets, in Patients With Autonomic… |
Vertigo |
Recruiting |
2025-06-15 |
| Phase 3 |
| NCT07595003 |
Efficacy, Safety, and Tolerability of 4-MUST, 128 mg Tablets in Chronic Cholecystitis and… |
Chronic Cholecystitis |
Recruiting |
2026-05-19 |
| Phase 2 |
| NCT07420985 |
Study to Evaluate the Efficacy, Safety, and Tolerability of the Ingavirin Forte Capsules… |
Influenza |
Recruiting |
2026-02-19 |
| NCT06842966 |
Efficacy, Safety, and Tolerability of 4-MUST Tablets in Chronic Cholecystitis and Biliary… |
Chronic Cholecystitis |
Recruiting |
2025-07-11 |
| NCT06843018 |
Study to Evaluate the Efficacy and Safety of Different Doses of Graminidin With… |
Pharyngitis Acute |
Recruiting |
2025-07-10 |
| Phase 1 |
| NCT07594977 |
Food-Effect, Single and Multiple Dose Pharmacokinetics, Safety and Tolerability Study of… |
Chronic Cholecystitis |
Recruiting |
2026-06-15 |
| NCT07645534 |
Safety and Pharmacokinetics of Ingavirin Forte, Capsules, 90 mg + 20 mg (Valenta Pharm… |
Influenza |
Recruiting |
2026-06-12 |
| NCT07421011 |
Pharmacokinetics, Bioequivalence, and Safety Study of Trimedat® 76,95 mg Orally… |
Irritable Bowel Syndrome |
Recruiting |
2026-02-19 |
| NCT06857890 |
Safety, Tolerability, and Pharmacokinetic Profile of Grammidin With Anesthetic, a Metered… |
Pharyngitis |
Recruiting |
2025-07-10 |
| NCT06859281 |
Safety, Tolerability, and Pharmacokinetic Profile of Grammidin, a Metered Dose Topical… |
Pharyngitis |
Recruiting |
2025-07-10 |
| NCT06859333 |
Study of the Safety, Tolerability, and Pharmacokinetic Profile of Ascending Doses of… |
Influenza |
Recruiting |
2025-07-08 |